16 employees
SomaServe is at the forefront of developing novel medications capable of crossing biological barriers.
2018
$2.9M
from 6 investors over 6 rounds
Somaserve raised $2.9M on April 20, 2021
Investors: Meltwind Advisory LLP, Origin Capital, o2h ventures and Abcam
Somaserve raised undisclosed on July 15, 2019
Investors: Oion and o2h ventures